BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11593156)

  • 21. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.
    Tremblay L; Pineton de Chambrun G; De Vroey B; Lavogiez C; Delaporte E; Colombel JF; Cortot A
    J Crohns Colitis; 2011 Oct; 5(5):457-60. PubMed ID: 21939920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxic epidermal necrolysis caused by flurazepam?
    Loncar C; Franić T; Bilusić M
    Psychiatr Danub; 2005 Dec; 17(3-4):236-9. PubMed ID: 16392434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic epidermal necrolysis with tracheobronchial and pulmonary complications.
    Kamata T; Sakamaki F; Fujita H; Urano T; Mori M; Yamaguchi K; Kanazawa M; Kai M; Izumi T; Naka W
    Intern Med; 1994 Apr; 33(4):252-5. PubMed ID: 8069023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal toxic epidermal necrolysis associated with minoxidil.
    Karaoui LR; Chahine-Chakhtoura C
    Pharmacotherapy; 2009 Apr; 29(4):460-7. PubMed ID: 19323621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fritsch P
    Eur J Dermatol; 2008; 18(2):216-7. PubMed ID: 18424404
    [No Abstract]   [Full Text] [Related]  

  • 27. Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fromowitz JS; Ramos-Caro FA; Flowers FP;
    Int J Dermatol; 2007 Oct; 46(10):1092-4. PubMed ID: 17910723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
    Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
    Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracheobronchial involvement in Churg-Strauss syndrome.
    Livi V; Cancellieri A; Patelli M; Trisolini R
    J Bronchology Interv Pulmonol; 2012 Jan; 19(1):81-2. PubMed ID: 23207273
    [No Abstract]   [Full Text] [Related]  

  • 30. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Prendiville J
    Adv Dermatol; 2002; 18():151-73. PubMed ID: 12528405
    [No Abstract]   [Full Text] [Related]  

  • 31. [HIV infection and Lyell syndrome: a wake-up call concerning anti-inflammatory agents].
    de Luis DA; Fortun J; Pintado V; Aller de la Fuente R
    Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):231-2. PubMed ID: 9312293
    [No Abstract]   [Full Text] [Related]  

  • 32. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
    Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
    Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchial obstruction due to respiratory mucosal sloughing in toxic epidermal necrolysis.
    Dasgupta A; O'Malley J; Mallya R; Williams JG
    Thorax; 1994 Sep; 49(9):935-6. PubMed ID: 7940439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.
    Tapia B; Padial A; Sánchez-Sabaté E; Alvarez-Ferreira J; Morel E; Blanca M; Bellón T
    J Allergy Clin Immunol; 2004 Aug; 114(2):335-40. PubMed ID: 15316512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro/SS-A and a review of the published work.
    Kamada N; Kinoshita K; Togawa Y; Kobayashi T; Matsubara H; Kohno M; Igari H; Kuriyama T; Nakamura M; Hirasawa H; Shinkai H
    J Dermatol; 2006 Sep; 33(9):616-22. PubMed ID: 16958806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 12-year retrospective study of non-burn skin loss (burn-like syndromes) at a tertiary burns unit in a developing country.
    Ugburo AO; Temiye EO; Ilombu CA
    Burns; 2008 Aug; 34(5):637-43. PubMed ID: 18226456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic epidermal necrolysis (TEN) Lyell's syndrome.
    Sehgal VN; Srivastava G
    J Dermatolog Treat; 2005; 16(5-6):278-86. PubMed ID: 16428146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
    Abe R
    J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case report: oxaprozin and fatal toxic epidermal necrolysis.
    Paul CN; Voigt DW; Clyne KE; Hansen SL
    J Burn Care Rehabil; 1998; 19(4):321-3. PubMed ID: 9710730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus, pregnancy, and Stevens-Johnson syndrome.
    Shilad A; Predanic M; Perni SC; Houlihan C; Principe D
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1254-6. PubMed ID: 15863600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.